<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Nebulisers; Jet nebulisers; Ultrasonic nebulisers" /><meta name="IX" content="Nebulisers; Jet nebulisers; Ultrasonic nebulisers" /><title>Nebulisers: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2964.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2964.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2964.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1008.htm">3 Respiratory system</a> &gt; <a href="2016.htm">3.1 Bronchodilators</a> &gt; <a href="2951.htm">3.1.5 Peak flow meters, inhaler devices and nebulisers</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2956.htm" title="Previous: Drug delivery devices">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2983.htm" title="Next: Nebuliser diluent">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>BNF for Children</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2964.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nebulisers</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 3 Respiratory system &gt; 3.1 Bronchodilators &gt; 3.1.5 Peak flow meters, inhaler devices, and nebulisers</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2964">Nebulisers</h1><?highlighter on?><div id="pC" class="jN"><div><div class="cN"><p>In England
and Wales nebulisers and compressors are not available on the NHS
(but they are free of VAT); some nebulisers (but not compressors)
are available on form GP10A in Scotland (for details consult Scottish
Drug Tariff).</p></div><p>A nebuliser converts a solution of a drug into an aerosol for
inhalation. It is used to deliver higher doses of drug to the airways
than is usual with standard inhalers. The main indications for use
of a nebuliser are to deliver:</p><ul class="cBF"><li><p class="cQ">a beta<sub>2</sub> agonist or ipratropium to a patient
with an <i>acute exacerbation </i>of asthma or of chronic
obstructive pulmonary disease;</p></li><li><p class="cQ">a beta<sub>2</sub> agonist, corticosteroid, or ipratropium
on a <i>regular basis</i> to a patient with severe asthma
or reversible airways obstruction when the patient is unable to use
other inhalational devices;</p></li><li><p class="cQ">an antibiotic (such as <span>colistimethate sodium</span>) or a mucolytic to a patient with cystic fibrosis;</p></li><li><p class="cQ">budesonide or adrenaline to a child with severe croup;</p></li><li><p class="cQ">pentamidine for the prophylaxis and treatment of pneumocystis
pneumonia.</p></li></ul><p>The use of nebulisers in chronic persistent asthma and chronic
obstructive pulmonary disease should be considered only:</p><ul class="cBF"><li><p class="cQ">after a review of the diagnosis;</p></li><li><p class="cQ">after review of therapy (see <a title="BNF:topic: Management of chronic asthma" href="119630.htm#_119630">Management of Chronic Asthma
table</a> and <a title="BNF:topic: Chronic obstructive pulmonary disease" href="100062.htm#_100062">Chronic Obstructive Pulmonary
Disease</a>)
and the patient’s ability to use hand-held devices;</p></li><li><p class="cQ">after increased doses of inhaled therapy from hand-held
inhalers (with a spacer if necessary) have been tried for 2 weeks;</p></li><li><p class="cQ">if the patient remains breathless, despite correctly using
optimal therapy</p></li></ul><p>Before prescribing a nebuliser, a home trial should preferably
be undertaken to monitor response for up to 2 weeks on standard treatment
and up to 2 weeks on nebulised treatment. If prescribed, patients
must:</p><ul class="cBF"><li><p class="cQ">have clear instructions from a doctor, specialist nurse,
physiotherapist, or pharmacist on the use of the nebuliser
(including maintenance and cleaning) and on peak-flow monitoring;</p></li><li><p class="cQ">be instructed not to treat acute attacks at home without
also seeking help;</p></li><li><p class="cQ">have regular follow up by a doctor, specialist nurse or
physiotherapist after about 1 month and annually thereafter</p></li></ul><p>The proportion of a nebuliser solution that reaches the lungs
depends on the type of nebuliser and although it can be as high as
30%, it is more frequently close to 10% and sometimes below 10%. The
remaining solution is left in the nebuliser as residual volume or
is deposited in the mouthpiece and tubing. The extent to which the
nebulised solution is deposited in the airways or alveoli depends
on the droplet size, pattern of breath inhalation, and condition of
the lung. Droplets with a mass median diameter of 1–5 microns are
deposited in the airways and are therefore appropriate for asthma,
whereas a particle size of 1–2 microns is needed for alveolar deposition
of pentamidine to combat pneumocystis infection. The type of nebuliser
is therefore chosen according to the deposition required and according
to the viscosity of the solution (antibiotic solutions usually being
more viscous).</p><p>Jet nebulisers
are more widely used than ultrasonic nebulisers. Most jet nebulisers
require an optimum gas flow rate of 6–8 litres/minute and in hospital
can be driven by piped air or oxygen; in acute asthma the nebuliser
should be driven by oxygen. Domiciliary oxygen cylinders do not provide
an adequate flow rate therefore an electrical compressor is required
for domiciliary use.</p><p>For patients at risk of hypercapnia, such as those with chronic
obstructive pulmonary disease, oxygen can be dangerous and the nebuliser
should be driven by air (see <a title="BNF:topic: Chronic obstructive pulmonary disease" href="100062.htm#_100062">section 3.1</a>). If oxygen
is required, it should be given simultaneously by nasal cannula.</p><div class="cN"><h3 class="cBP">Tubing</h3><p>The Department of Health has reminded users of the need to use
the correct grade of tubing when connecting a nebuliser to a medical
gas supply or compressor.</p></div><p>Ultrasonic
nebulisers produce an aerosol by ultrasonic vibration of the drug
solution and therefore do not require a gas flow; they are not suitable
for the nebulisation of some drugs, such as dornase alfa and nebulised
suspensions.</p></div></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2956.htm">Previous: Drug delivery devices</a> | <a class="top" href="2964.htm#">Top</a> | <a accesskey="]" href="2983.htm">Next: Nebuliser diluent</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>